Recurrent Metastatic Penile Cancer Patient with Positive PD-L1 Expression Obtained Significant Benefit from Immunotherapy: A Case Report and Literature Review

por Su, Xiangyu, Zhang, Jing, Fu, Chenchun, Xiao, Mingzhe, Wang, Cailian
Publicado 2020

A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma

por Peng, Wei, Li, Si, Li, Lijian, Xiao, Mingzhe, Zhong, Jincai
Publicado 2020

SIRT4-Catalyzed Deacetylation of Axin1 Modulates the Wnt/β-Catenin Signaling Pathway

por Wang, Yuting, Yue, Jicheng, Xiao, Mingzhe, Lu, Xiaomei, Chin, Yuen Eugene
Publicado 2022

Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity

por Wang, Miao, Zhu, Qiguo, Fu, Jianguo, Liu, Lilong, Xiao, Mingzhe, Du, Yu
Publicado 2020

Significant benefit of nivolumab combining radiotherapy in metastatic gallbladder cancer patient with strong PD-L1 expression: a case report

por Kong, Weiwei, Wei, Jia, Liu, Juan, Qiu, Yudong, Shi, Jiong, He, Jian, Su, Mu, Xiao, Mingzhe, Liu, Baorui
Publicado 2019

Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity

por Chen, Qiang, Yan, Yan, Yang, Chuanping, Liu, Guangjun, Wang, Gaoming, Li, Si, Chen, Dongsheng, Xiao, Mingzhe, Wu, Yanmin
Publicado 2021

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

por Dong, Changqing, Cheng, Wanwan, Zhang, Meiling, Li, Si, Zhao, Lele, Chen, Dongsheng, Qin, Yong, Xiao, Mingzhe, Fang, Shencun
Publicado 2022

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non‐small cell lung cancer

por Dong, Yiting, Zhao, Lele, Duan, Jianchun, Bai, Hua, Chen, Dongsheng, Li, Si, Yu, Yangyang, Xiao, Mingzhe, Zhang, Qin, Duan, Qianqian, Sun, Tingting, Qi, Chuang, Wang, Jie, Wang, Zhijie
Publicado 2022